We have located links that may give you full text access.
Does the diagnostic Accuracy and Rates of face-to-face visits occurring shortly after an asynchronized Tele-dermatology consultations justify its implementation: An 18-month Cohort Study.
INTRODUCTION: In 2019, Maccabi Health Services (MHS), rolled out the store-and-forward "Dermadetect" teledermatology consultation (TC) application. Study goal was to analyze MHS records of TCs (August 2019-February 2021) for the rate and reasons for face to face consultations (FTFC) occurring shortly after a TC with emphasis on FTFCs resulting in a different diagnosis for the same indication.
METHODS: The records of FTFCs held up shortly after TCs were reviewed and classified into cases marked as unsuited for tele-dermatology, cases which the indication differed and cases with the same indication which were analyzed for concordance of diagnoses.
RESULTS: Dermadetect was used by 12815 MHS beneficiaries. In 30% of cases, a following FTFC occurred within the subsequent 5 months and 901 of them occurred in the subsequent 2 weeks and were analyzed: Thirty percent were not suited for tele-dermatology, 15% were held for a different indication and 55% occurred for same indication. The diagnosis concordance between the TC and recurrent FTFC for the same indication was 97.4%, with full concordance at 68.1% and partial concordance at 29.3%.Overall, 13 patients (1.4%) of the 901 patients using the application only once had a subsequent FTFC within 2 weeks and received a different diagnosis than the one given in the TC.
CONCLUSIONS: When considering the implementation of store and forward TC's, a 30% rate of a following FTFC's during the next 5 months should be considered when planning the reimbursement model. Diagnosis discordance may be disregarded due its low rates.
METHODS: The records of FTFCs held up shortly after TCs were reviewed and classified into cases marked as unsuited for tele-dermatology, cases which the indication differed and cases with the same indication which were analyzed for concordance of diagnoses.
RESULTS: Dermadetect was used by 12815 MHS beneficiaries. In 30% of cases, a following FTFC occurred within the subsequent 5 months and 901 of them occurred in the subsequent 2 weeks and were analyzed: Thirty percent were not suited for tele-dermatology, 15% were held for a different indication and 55% occurred for same indication. The diagnosis concordance between the TC and recurrent FTFC for the same indication was 97.4%, with full concordance at 68.1% and partial concordance at 29.3%.Overall, 13 patients (1.4%) of the 901 patients using the application only once had a subsequent FTFC within 2 weeks and received a different diagnosis than the one given in the TC.
CONCLUSIONS: When considering the implementation of store and forward TC's, a 30% rate of a following FTFC's during the next 5 months should be considered when planning the reimbursement model. Diagnosis discordance may be disregarded due its low rates.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app